410 related articles for article (PubMed ID: 19561557)
1. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
Niebler RA; Punzalan RC; Marchan M; Lankiewicz MW
Pediatr Crit Care Med; 2010 Jan; 11(1):98-102. PubMed ID: 19561557
[TBL] [Abstract][Full Text] [Related]
2. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery.
Wittenstein B; Ng C; Ravn H; Goldman A
Pediatr Crit Care Med; 2005 Jul; 6(4):473-6. PubMed ID: 15982438
[TBL] [Abstract][Full Text] [Related]
3. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.
Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD
Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857
[TBL] [Abstract][Full Text] [Related]
4. Activated recombinant factor VII and extracorporeal membrane oxygenation: everything is all right, nothing is wrong?
Dominguez TE; Brown KL
Pediatr Crit Care Med; 2010 Jan; 11(1):155-6. PubMed ID: 20051799
[No Abstract] [Full Text] [Related]
5. Safety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review.
Long MT; Wagner D; Maslach-Hubbard A; Pasko DA; Baldridge P; Annich GM
Perfusion; 2014 Mar; 29(2):163-70. PubMed ID: 23942787
[TBL] [Abstract][Full Text] [Related]
6. Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation.
Chalwin RP; Tiruvoipati R; Peek GJ
Eur J Cardiothorac Surg; 2008 Sep; 34(3):685-6. PubMed ID: 18579402
[TBL] [Abstract][Full Text] [Related]
7. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
8. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
9. The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life.
Northrop MS; Sidonio RF; Phillips SE; Smith AH; Daphne HC; Pietsch JB; Bridges BC
Pediatr Crit Care Med; 2015 Jan; 16(1):66-74. PubMed ID: 25319630
[TBL] [Abstract][Full Text] [Related]
10. Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation.
Anselmi A; Guinet P; Ruggieri VG; Aymami M; Lelong B; Granry S; Malledant Y; Le Tulzo Y; Gueret P; Verhoye JP; Flecher E
Eur J Cardiothorac Surg; 2016 Jan; 49(1):78-84. PubMed ID: 25908783
[TBL] [Abstract][Full Text] [Related]
11. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal membrane oxygenation for refractory septic shock in children: one institution's experience.
Maclaren G; Butt W; Best D; Donath S; Taylor A
Pediatr Crit Care Med; 2007 Sep; 8(5):447-51. PubMed ID: 17693912
[TBL] [Abstract][Full Text] [Related]
13. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
Verrijckt A; Proulx F; Morneau S; Vobecky S
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1812-3. PubMed ID: 15173742
[No Abstract] [Full Text] [Related]
14. rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease.
Veldman A; Neuhaeuser C; Akintuerk H; Thul J; Gehron J; Schranz D; Michel-Behnke I
Paediatr Anaesth; 2007 Dec; 17(12):1176-81. PubMed ID: 17986036
[TBL] [Abstract][Full Text] [Related]
15. Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery.
Bowman LJ; Uber WE; Stroud MR; Christiansen LR; Lazarchick J; Crumbley AJ; Kratz JM; Toole JM; Crawford FA; Ikonomidis JS
Ann Thorac Surg; 2008 May; 85(5):1669-76; discussion 1676-7. PubMed ID: 18442563
[TBL] [Abstract][Full Text] [Related]
16. Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure.
Pettignano R; Fortenberry JD; Heard ML; Labuz MD; Kesser KC; Tanner AJ; Wagoner SF; Heggen J
Pediatr Crit Care Med; 2003 Jul; 4(3):291-8. PubMed ID: 12831409
[TBL] [Abstract][Full Text] [Related]
17. Indication for initiation of mechanical circulatory support impacts survival of infants with shunted single-ventricle circulation supported with extracorporeal membrane oxygenation.
Allan CK; Thiagarajan RR; del Nido PJ; Roth SJ; Almodovar MC; Laussen PC
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):660-7. PubMed ID: 17320562
[TBL] [Abstract][Full Text] [Related]
18. Antithrombin replacement during extracorporeal membrane oxygenation.
Niebler RA; Christensen M; Berens R; Wellner H; Mikhailov T; Tweddell JS
Artif Organs; 2011 Nov; 35(11):1024-8. PubMed ID: 22097980
[TBL] [Abstract][Full Text] [Related]
19. Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery.
Singh SP; Chauhan S; Choudhary M; Vasdev S; Talwar S
Asian Cardiovasc Thorac Ann; 2012 Feb; 20(1):19-23. PubMed ID: 22371937
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
Karsies TJ; Nicol KK; Galantowicz ME; Stephens JA; Kerlin BA
Ann Thorac Surg; 2010 Feb; 89(2):570-6. PubMed ID: 20103344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
